VYGR
Voyager Therapeutics Inc
2.50$
-8.4%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 311.6% | 538.7% | 961.2% | 1,299.9% | 1,703.9% | 210.0% | 1,576.8% | 641.0% | 794.3% | 842.3% | 477.8% | 54.9% | 145.7% | 111.9% | 178.7% | 102.6% | 21.2% | 336.5% | 343.7% | 1,437.4% | 1,208.8% | 49.9% | 2,180.7% | 1,759.4% | 47.1% | – | 12.3% | 453.0% | 560.5% | 1.5% | 6.1% | 108.0% | 122.8% | 522.6% | 487.0% | 602.5% | 268.4% | 218.8% | 35.9% | – | – | |
| -211.6% | -438.7% | -861.2% | -1,199.9% | -1,603.9% | -110.0% | -1,476.8% | -541.0% | -694.3% | -742.3% | -377.8% | 45.1% | -45.7% | -11.9% | -78.7% | -2.6% | 78.8% | -236.5% | -243.7% | -1,337.4% | -1,108.8% | 50.1% | -2,080.7% | -1,659.4% | 52.9% | – | 87.7% | -353.0% | -460.5% | 98.5% | 93.9% | -8.0% | -22.8% | -422.6% | -387.0% | -502.5% | -168.4% | -118.8% | 64.1% | 100.0% | -104.2% | |
| 311.6% | 538.7% | 961.2% | 1,299.9% | 1,703.9% | 210.0% | 1,576.8% | 641.0% | 794.3% | 842.3% | 477.8% | 62.0% | 145.7% | 111.9% | 178.7% | 102.6% | 21.2% | 336.5% | 343.7% | 1,437.4% | 1,208.8% | 49.9% | 2,180.7% | 1,759.4% | 47.1% | – | 12.3% | 453.0% | 560.5% | 27.1% | 132.7% | 116.5% | 122.8% | 566.8% | 487.0% | 602.5% | 268.4% | 234.4% | 948.8% | 696.4% | 343.8% | |
| 101.9% | 147.4% | 335.7% | 383.7% | 430.5% | 84.6% | 762.4% | 456.8% | 315.6% | 411.1% | 185.9% | 18.1% | 41.4% | 30.3% | 56.5% | 28.7% | 7.0% | 126.5% | 149.9% | 769.1% | 588.0% | 29.7% | 1,164.0% | 1,060.7% | 17.8% | – | 6.0% | 170.9% | 179.0% | 11.4% | 44.1% | 34.3% | 33.2% | 143.3% | 148.9% | 201.8% | 60.6% | 53.6% | 318.6% | 237.5% | 93.1% | |
| 413.5% | 686.0% | 1,296.9% | 1,683.6% | 2,134.4% | 294.6% | 2,339.2% | 1,097.8% | 1,109.9% | 1,253.4% | 663.7% | 80.1% | 187.1% | 30.3% | 56.5% | 28.7% | 7.0% | 126.5% | 149.9% | 769.1% | 588.0% | 29.7% | 1,164.0% | 1,060.7% | 17.8% | – | 6.0% | 170.9% | 179.0% | 38.5% | 176.8% | 42.8% | 33.2% | 187.5% | 148.9% | 201.8% | 60.6% | 76.4% | 1,231.4% | 933.9% | 235.9% | |
| -313.5% | -586.0% | -1,196.9% | -1,583.6% | -2,034.4% | -194.6% | -2,239.2% | -997.8% | -1,009.9% | -1,153.4% | -563.7% | 19.9% | -87.1% | -42.1% | -135.2% | -31.3% | 71.7% | -363.0% | -393.6% | -2,106.5% | -1,696.8% | 20.3% | -3,244.7% | -2,720.1% | 35.2% | – | 81.7% | -523.9% | -639.5% | 60.0% | -82.9% | -50.8% | -56.0% | -610.1% | -536.0% | -704.3% | -228.9% | -195.2% | -1,167.4% | -833.9% | -340.1% | |
| 35.4% | 41.3% | 17.3% | 21.7% | 25.3% | 0.0% | 62.4% | 33.8% | 45.0% | 0.0% | 22.0% | 4.6% | 8.9% | – | 5.4% | 1.2% | 0.2% | 1.2% | 0.3% | 3.5% | 8.2% | 2.3% | 4.7% | 30.8% | 1.3% | – | 2.0% | 67.5% | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| -281.1% | -606.2% | -1,152.6% | -1,587.2% | -2,033.6% | -185.9% | -2,134.4% | -991.9% | -968.9% | -1,122.1% | -522.8% | 24.2% | -73.4% | -38.5% | -134.3% | -30.3% | 72.6% | -243.6% | -333.0% | -2,219.6% | -1,696.2% | 20.3% | -3,240.0% | -2,680.8% | 42.9% | – | 82.9% | -456.4% | -557.5% | 63.5% | -58.0% | -34.2% | -36.5% | -540.0% | -478.7% | -641.7% | -208.1% | -178.8% | -1,076.9% | -772.6% | -312.3% | |
| -9.2% | 15.0% | -15.4% | 16.6% | -42.2% | 0.5% | -19.1% | 1.4% | -45.0% | -28.8% | -22.0% | -4.6% | -8.9% | -2.3% | -5.4% | -1.2% | -0.2% | -1.2% | -0.3% | -3.5% | -8.2% | -5.3% | -4.7% | -30.8% | -1.3% | – | 0.5% | 1.2% | 3.8% | 0.9% | 0.1% | 0.1% | 0.2% | 9.3% | 0.6% | 0.3% | 0.6% | 0.1% | 0.5% | 0.6% | 0.4% | |
| -271.9% | -621.3% | -1,137.2% | -1,603.7% | -2,033.6% | -185.5% | -2,115.3% | -991.9% | -968.9% | -1,122.1% | -522.8% | 24.2% | -73.4% | -38.5% | -134.3% | -30.3% | 72.6% | -243.6% | -333.0% | -2,219.6% | -1,696.2% | 20.3% | -3,240.0% | -2,680.8% | 42.9% | – | 82.4% | -457.6% | -561.4% | 62.6% | -58.1% | -34.3% | -36.7% | -549.3% | -479.2% | -642.0% | -208.7% | -178.8% | -1,077.4% | -773.2% | -312.6% | |
| -308.7% | -579.1% | -1,175.2% | -1,548.9% | -1,996.7% | -187.7% | -2,190.8% | -971.8% | -982.9% | -1,093.3% | -551.8% | 25.7% | -83.6% | -39.8% | -130.6% | -28.1% | 72.6% | -347.9% | -374.0% | -2,132.3% | -1,613.6% | 27.9% | -2,812.6% | -2,511.7% | 46.2% | – | 83.6% | -434.0% | -537.0% | 65.0% | -51.9% | -37.6% | -32.0% | -523.9% | -463.0% | -621.2% | -201.1% | -171.9% | -1,040.9% | -714.5% | -298.5% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.